Yuhan Corporation signs supply agreement of AIDS treatments and APIs with Gilead Sciences

Yuhan Corporation announced on the 8^th that the company has signed a supply agreement of its AIDS(acquired immunodeficiency syndrome) treatments and HIV APIs(active pharmaceutical ingredients) with ‘Gilead Sciences Ireland UC.’

The agreed price was KRW 65.4 billion(4.95% of Yuhan Corporation’s KRW 1.32 trillion sales); the starting date of the agreement was 8 December 2017 and the ending date ...